Correlations between histopathological findings and clinical manifestations in biopsy-proven giant cell arteritis

被引:37
|
作者
Muratore, Francesco [1 ]
Boiardi, Luigi [1 ]
Cavazza, Alberto [2 ]
Aldigeri, Raffaella [3 ]
Pipitone, Nicolo [1 ]
Restuccia, Giovanna [1 ]
Bellafiore, Salvatore [2 ]
Cimino, Luca [4 ]
Salvarani, Carlo [1 ]
机构
[1] Azienda Osped ASMN, Ist Ricovero & Cura Carattere Sci, Dept Internal Med, Rheumatol Unit, Reggio Emilia, Italy
[2] Azienda Osped ASMN, Ist Ricovero & Cura Carattere Sci, Dept Oncol, Pathol Unit, Reggio Emilia, Italy
[3] Univ Parma, Dept Clin & Expt Med, I-43100 Parma, Italy
[4] Azienda Osped ASMN, Ist Ricovero & Cura Carattere Sci, Dept Surg, Ophthalmol Unit, Reggio Emilia, Italy
关键词
Temporal artery biopsy; Giant cell arteritis; Temporal arteritis; Visual loss; Ischemic complications; Histopathology; Colour duplex ultrasonography; POPULATION-BASED COHORT; TEMPORAL ARTERITIS; RISK-FACTORS; ISCHEMIC COMPLICATIONS; POLYMYALGIA-RHEUMATICA; VISUAL-LOSS; INTIMAL HYPERPLASIA; ANGIOGENIC ACTIVITY; FEATURES; PATTERNS;
D O I
10.1016/j.jaut.2016.03.005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To correlate histopathological features of positive temporal artery biopsy (TAB) and clinical manifestations of the disease in a large single-center population-based cohort of patients with biopsy proven giant cell arteritis (GCA). Methods: A pathologist with expertise in vasculitis and blinded to clinical data and final diagnosis reviewed all TABs performed for suspected GCA at our hospital between January 1986 and December 2013. Histopathologic features evaluated were: the severity of inflammation and intimal hyperplasia, both graded on a semiquantitative scale (mild = 1, moderate = 2, severe = 3), the presence of intraluminal acute thrombosis, calcifications, giant cells, fibrinoid necrosis and laminar necrosis. Results: 274 patients had a final diagnosis of biopsy-proven GCA and were included in the study. Cranial ischemic events (CIEs) were observed in 161 (58.8%), visual manifestations in 79 (28.8%) and permanent (partial or complete) visual loss in 51 (18.6%) patients. Predictors for the development of CIEs were older age (OR = 1.057, 95% CI 1.019-1.097, p = 0.003), lower ESR values (OR = 0.990, 95% CI 0.981-0.999, p = 0.026) as well as the presence of giant cells (OR = 1.848, 95% CI 1.045-3.269, p = 0.035) and laminar necrosis at TAB (OR = 2.334, 95% CI 1.187-4.587, p = 0.014). Predictors for the development of permanent visual loss were lower CRP values (OR = 0.906, 95% CI 0.827-0.992, p = 0.033) and the presence of calcifications at TAB (OR = 3.672, 95% CI 1.479-9.121, p = 0.005). Fibrinoid necrosis was not observed in any of the TABs evaluated. Conclusion: Pathological features of TAB may predict some manifestations of GCA. These findings may have implications for patients' management. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:94 / 101
页数:8
相关论文
共 50 条
  • [1] Correlations Between Histopathological Findings and Clinical Manifestations in a Large Monocentric Cohort of Patients with Biopsy-Proven Giant Cell Arteritis.
    Boiardi, Luigi
    Muratore, Francesco
    Restuccia, Giovanna
    Cavazza, Alberto
    Macchioni, Pierluigi
    Germano, Giuseppe
    Pipitone, Nicolo
    Salvarani, Carlo
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S346 - S346
  • [2] CLINICAL MANIFESTATIONS OF BIOPSY-PROVEN GIANT CELL ARTERITIS
    WILSKE, KR
    HEALEY, LA
    ARTHRITIS AND RHEUMATISM, 1971, 14 (03): : 424 - &
  • [3] COMPARISON OF HISTOPATHOLOGICAL FINDINGS WITH CLINICAL MANIFESTATIONS IN A LARGE SINGLE CENTER COHORT OF PATIENTS WITH BIOPSY-PROVEN GIANT CELL ARTERITIS
    Muratore, F.
    Boiardi, L.
    Restuccia, G.
    Cavazza, A.
    Macchioni, P.
    Germano, G.
    Pipitone, N.
    Salvarani, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 690 - 690
  • [4] Comparison of Clinical Manifestations in Different Histological Subsets of Biopsy-Proven Giant Cell Arteritis.
    Boiardi, Luigi
    Muratore, Francesco
    Cavazza, Alberto
    Restuccia, Giovanna
    Macchioni, Pierluigi
    Germano, Giuseppe
    Pipitone, Nicolo
    Bajocchi, Gianluigi
    Salvarani, Carlo
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S346 - S347
  • [5] Thrombocytosis in patients with biopsy-proven giant cell arteritis
    Foroozan, R
    Danesh-Meyer, H
    Savino, PJ
    Gamble, G
    Mekari-Sabbagh, ON
    Sergott, RC
    OPHTHALMOLOGY, 2002, 109 (07) : 1267 - 1271
  • [6] Atherosclerosis in patients with biopsy-proven giant cell arteritis
    Gonzalez-Juanatey, Carlos
    Lopez-Diaz, Maria J.
    Martin, Javier
    Llorca, Javier
    Gonzalez-Gay, Miguel A.
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2007, 57 (08): : 1481 - 1486
  • [7] SURVIVAL OF BIOPSY PROVEN GIANT CELL ARTERITIS IN NORTHERN ITALY: CORRELATION WITH CLINICAL, LABORATORY AND HISTOPATHOLOGICAL FINDINGS
    Macchioni, P.
    Boiardi, L.
    Muratore, F.
    Catanoso, M.
    Cavazza, A.
    Mancuso, P.
    Cimino, L.
    Restuccia, G.
    Salvarani, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 440 - 440
  • [8] Survival of Biopsy Proven Giant Cell Arteritis in Northern Italy: Correlation with Clinical, Laboratory and Histopathological Findings
    Boiardi, Luigi
    Macchioni, Pierluigi
    Muratore, Francesco
    Catanoso, Mariagrazia
    Cavazza, Alberto
    Mancuso, Pamela
    Cimino, Luca
    Restuccia, Giovanna
    Salvarani, Carlo
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [9] Fever in biopsy-proven giant cell arteritis: Clinical implications in a defined population
    Gonzalez-Gay, MA
    Garcia-Porrua, C
    Amor-Dorado, JC
    Llorca, J
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2004, 51 (04): : 652 - 655
  • [10] PREVALENCE OF BIOPSY-PROVEN GIANT CELL ARTERITIS IN SOUTHERN SWEDEN
    Stamatis, Pavlos
    Turkiewicz, Aleksandra
    Englund, Martin
    Turesson, Carl
    Mohammad, Aladdin
    RHEUMATOLOGY, 2019, 58 : 72 - 72